Table 3 Relationship between background, clinical, laboratory predictors and all-cause mortality
Variables | All-cause mortality | Multivariate Results | |||
|---|---|---|---|---|---|
Yes (n = 44) | No (n = 267) | ||||
Frequency | Frequency | P-value | Adjusted P-value | Adjusted OR (CI 95%) | |
Age at baseline(Mean ± SD) | 64.4 ± 8.7 | 60.4 ± 10.3 | 0.014 | 0.831 | 1.01 (0.95–1.1) |
Gender | |||||
Male | 29 (19.1%) | 123 (80.9%) | 0.015 | 0.701 | 0.79 (0.24–2.6) |
Female* | 15 (9.4%) | 144 (90.6%) | |||
BMI at baseline (Mean ± SD) | 32.3 ± 6 | 32.9 ± 5.7 | 0.522 | ||
Smoker | |||||
Yes | 15 (15.6%) | 81 (84.4%) | 0.478 | 0.987 | 0.99 (0.3–3.2) |
No* | 26 (12.6%) | 180 (87.4%) | |||
Hypertension | |||||
Yes | 37 (15.4%) | 204 (84.6%) | 0.149 | 0.740 | 0.75 (0.14–4.1) |
No* | 5 (8.2%) | 56 (91.8%) | |||
HTN duration at baseline(Mean ± SD) | 9.8 ± 8 | 8.7 ± 7.6 | 0.411 | ||
DM duration at baseline (Mean ± SD) | 13.6 ± 9.4 | 12.3 ± 8 | 0.331 | ||
eGFR at baseline (Mean ± SD) | 55.7 ± 26.4 | 76.6 ± 22.2 | < 0.001 | ||
IRF at baseline (eGFR < 60) | |||||
Yes | 27 (32.1%) | 57 (67.9%) | 0.002 | 5.5 (1.8–16.8) | |
No* | 17 (7.5%) | 210 (92.5%) | < 0.001 | ||
GFR decline | |||||
Yes | 18 (16.7%) | 90 (83.3%) | < 0.001 | 0.001 | 10.8 (2.8–41.6) |
No* | 3 (1.7%) | 177 (98.3%) | |||
HbA1C at baseline (Mean ± SD) | 8.1 ± 1.8 | 8.5 ± 2.1 | 0.215 | ||
HDL cholesterol at baseline(Mean ± SD) | 47.9 ± 12.2 | 47.2 ± 14.2 | 0.857 | ||
LDL cholesterol at baseline(Mean ± SD) | 92.7 ± 35.5 | 87.9 ± 29.3 | 0.535 | ||